Εμφάνιση απλής εγγραφής

dc.creatorPolitis C., Parara M., Kremastinou J., Hasapopoulou E., Iniotaki A., Siorenta A., Richardson C., Papa A., Kavallierou L., Asariotou M., Katsarou O., Mougiou A., Dadiotis L., Alexandropoulou Z., Megalou A., Magoula E., Papadopoulou M., Pervanidou D., Baka A., Hadjichristodoulou C.en
dc.date.accessioned2023-01-31T09:50:22Z
dc.date.available2023-01-31T09:50:22Z
dc.date.issued2016
dc.identifier10.1111/trf.13667
dc.identifier.issn00411132
dc.identifier.urihttp://hdl.handle.net/11615/78293
dc.description.abstractBACKGROUND: West Nile virus (WNV) infection, commonly asymptomatic, may cause mild West Nile fever (WNF) or potentially fatal neuroinvasive disease (WNND). An outbreak of 262 cases of the new Lineage 2 strain in Greece in 2010 continued with high mortality (17%) in WNND. The objective was to investigate ABO, D, and Lewis blood groups, as well as HLA Class I and Class II alleles, in relation to WNV Lineage 2 disease morbidity. STUDY DESIGN AND METHODS: A cohort of 132 Greek WNV cases in 2010 to 2013 (65% male; mean age 64 years; 41% WNF, 59% WNND) was compared to 51,339 healthy WNV-negative blood donors and 246 healthy subjects. RESULTS: Blood group A was more common in WNV cases (51%) than blood donors (39%) and group O less common (32% vs. 42%). D negativity within group A was higher in WNV than in blood donors (18% vs. 10%, p = 0.044). The frequency of secretors (Lewis(a–b+)) was 60% in WNV and 68% in donors (p = 0.16). HLA alleles C*08, DRB1*O4:O5, and DQB1*O2 occurred significantly less frequently in WNV than controls (p < 0.05 unadjusted for multiple testing) and DRB1*10:O1 more frequently (p = 0.039). CONCLUSION: This first study of symptomatic WNV Lineage 2 suggests A/D negativity as a new risk factor associated with WNV infection and level of morbidity. Further studies are required of the possibility that HLA C*08, DRB1*O4:O5, and DQB1*O2 are protective alleles and DRB1*10:O1 a “susceptible” allele to WNV infection and the role of secretor status in relation to WNV infection. © 2016 AABBen
dc.language.isoenen
dc.sourceTransfusionen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84982969247&doi=10.1111%2ftrf.13667&partnerID=40&md5=f085c40ea43d45aacc536939e864987c
dc.subjectHLA antigen class 1en
dc.subjectHLA antigen class 2en
dc.subjectHLA C antigenen
dc.subjectHLA DQB1 antigenen
dc.subjectHLA DRB1 antigenen
dc.subjectadulten
dc.subjectageden
dc.subjectArticleen
dc.subjectblood group ABO systemen
dc.subjectblood group Lewis systemen
dc.subjectcohort analysisen
dc.subjectcontrolled studyen
dc.subjectfemaleen
dc.subjectgene frequencyen
dc.subjectGreeceen
dc.subjectHLA typingen
dc.subjecthumanen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmorbidityen
dc.subjectoutcome assessmenten
dc.subjectrisk factoren
dc.subjectvirus infectionen
dc.subjectWest Nile virusen
dc.subjectBlackwell Publishing Inc.en
dc.titleAssociations of ABO, D, and Lewis blood groups and HLA Class I and Class II alleles with West Nile virus Lineage 2 disease outcome in Greece, 2010 to 2013en
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής